Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹-547 Cr₹-38 Cr₹389 Cr₹19 Cr₹255 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS is ₹-547 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹-547 Cr
Mar2025₹-38 Cr
Mar2024₹389 Cr
Mar2023₹19 Cr
Mar2022₹255 Cr

How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹-547 Cr
Negative
Mar2025 ₹-38 Cr
Negative
Mar2024 ₹389 Cr
1,902.17
Mar2023 ₹19 Cr
-92.37
Mar2022 ₹255 Cr -

Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,915.9 Cr 5.4% -3.5% 22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,803.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹253,833.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,461.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,463.0 Cr 7.8% 11% 1.2% Stock Analytics
CIPLA ₹109,870.0 Cr 2.3% -2.7% -18.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.4%

-3.5%

22.3%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses